Canada Life’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $238M | Sell |
1,460,001
-66,362
| -4% | -$11.1M | 0.39% | 43 |
|
|
2026
Q2 | $285M | Buy |
1,526,363
+4,497
| +0.3% | +$846K | 0.45% | 37 |
|
|
2026
Q1 | $296M | Buy |
1,521,866
+1,520,623
| +122,335% | +$293M | 0.53% | 30 |
|
|
2025
Q4 | $229K | Buy |
1,243
+634
| +104% | +$111K | ﹤0.01% | 1603 |
|
|
2025
Q3 | $90K | Buy |
609
+118
| +24% | +$17.9K | ﹤0.01% | 1774 |
|
|
2025
Q2 | $69K | Buy |
491
+38
| +8% | +$5.33K | ﹤0.01% | 1808 |
|
|
2025
Q1 | $67K | Buy |
453
+82
| +22% | +$11.9K | ﹤0.01% | 1830 |
|
|
2024
Q4 | $49K | Sell |
371
-153
| -29% | -$21.4K | ﹤0.01% | 1893 |
|
|
2024
Q3 | $82K | Buy |
524
+129
| +33% | +$20.8K | ﹤0.01% | 1890 |
|
|
2024
Q2 | $62K | Buy |
395
+142
| +56% | +$21.4K | ﹤0.01% | 1946 |
|
|
2024
Q1 | $34K | Buy |
253
+73
| +41% | +$9.7K | ﹤0.01% | 2047 |
|
|
2023
Q4 | $24K | Sell |
180
-350
| -66% | -$45.5K | ﹤0.01% | 2085 |
|
|
2023
Q3 | $72K | Buy |
530
+265
| +100% | +$36.2K | ﹤0.01% | 2027 |
|
|
2023
Q2 | $38K | Sell |
265
-910
| -77% | -$134K | ﹤0.01% | 2034 |
|
|
2023
Q1 | $163K | Buy |
1,175
+479
| +69% | +$64.4K | ﹤0.01% | 1899 |
|
|
2022
Q4 | $94K | Buy |
696
+174
| +33% | +$21.8K | ﹤0.01% | 1997 |
|
|
2022
Q3 | $57K | Buy |
522
+134
| +35% | +$17K | ﹤0.01% | 2076 |
|
|
2022
Q2 | $51K | Buy |
388
+125
| +48% | +$16.4K | ﹤0.01% | 2055 |
|
|
2022
Q1 | $36K | Buy |
263
+133
| +102% | +$16K | ﹤0.01% | 2234 |
|
|
2021
Q4 | $15K | Sell |
130
-168,099
| -100% | -$19.8M | ﹤0.01% | 2416 |
|
|
2021
Q3 | $20.3M | Buy |
+168,229
| New | +$19.6M | 0.05% | 393 |
|
|
2017
Q4 | – | Sell |
-158,376
| Closed | -$10.7M | – | 2548 |
|
|
2017
Q3 | $10.7M | Buy |
+158,376
| New | +$10M | 0.03% | 502 |
|
|
2015
Q3 | – | Sell |
-17,436
| Closed | -$1.11M | – | 2450 |
|
|
2015
Q2 | $1.11M | Buy |
17,436
+8
| +0% | +$548 | ﹤0.01% | 903 |
|
|
2015
Q1 | $1.19M | Sell |
17,428
-237
| -1% | -$16.5K | ﹤0.01% | 889 |
|
|
2014
Q4 | $1.24M | Buy |
17,665
+4,300
| +32% | +$308K | ﹤0.01% | 870 |
|
|
2014
Q3 | $955K | Buy |
13,365
+5,300
| +66% | +$388K | ﹤0.01% | 896 |
|
|
2014
Q2 | $598K | Hold |
8,065
| – | – | ﹤0.01% | 902 |
|
|
2014
Q1 | $521K | Buy |
+8,065
| New | +$521K | ﹤0.01% | 906 |
|
Other funds holding AZN
Canada Life's AZN Position: Q3 2026 in Review
Canada Life reduced its AstraZeneca (AZN) stake by 4.3% in Q3 2026, selling an estimated $11.1M and leaving 1,460,001 shares worth $238M. The position accounts for 0.39% of the portfolio, ranked #43.
Canada Life first reported a position in AZN in Q1 2014 and has held it in 28 quarters since. The position peaked at $296M in Q1 2026. 1,206 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Canada Life held 1,460,001 shares of AstraZeneca worth $238M as of Q3 2026.
- Canada Life sold 66,362 AstraZeneca shares in Q3 2026, an estimated $11.1M.
- AstraZeneca made up 0.39% of Canada Life's portfolio in Q3 2026, its #43 holding.
- Canada Life first reported a position in AstraZeneca in Q1 2014 and has held it in 28 quarters since.
- Canada Life's AstraZeneca position peaked at $296M in Q1 2026.
- 1,206 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Canada Life's 13F filing for Q3 2026, filed 13 Nov 2026.